MoonLake Immunotherapeutics MLTX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's operating lease ROU assets?
- MoonLake Immunotherapeutics (MLTX) reported operating lease ROU assets of 6.4% in Q1 2026.
- How has MoonLake Immunotherapeutics's operating lease ROU assets changed year-over-year?
- MoonLake Immunotherapeutics's operating lease ROU assets increased by 36.2% year-over-year, from 4.7% to 6.4%.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.